OCT News and Research

RSS

ProUroScan prostate imaging system 510(k) application: Inclement weather delays FDA processing

ProUroCare Medical, Inc., a provider of proprietary medical imaging products, indicates that the Food and Drug Administration has informed the industry that the processing of 510(k) applications, which includes the ProUroScan™ prostate imaging system, has been delayed because of the inclement weather in February that impacted the Washington, D.C. area.

26 Feb 2010

AMA calls for fix to Medicare's doctor payments

With a sizable cut to Medicare physician payments taking effect in just one week, the American Medical Association is seeking clarity from Congress on its plan of action to stop the 21.2% reduction.

23 Feb 2010

Cappella promotes serial IVUS analysis & Sideguard 3.25 device at Rome JIM

Cappella, Inc. (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, promoted their serial IVUS analysis & Sideguard® 3.25 device during the Joint Interventional Meeting (JIM) in Rome. Gary S. Mintz, MD, Cardiovascular Research Foundation, New York, USA presented "Positive Vessel Remodeling Using Sideguard in Coronary Bifurcations" during the New Technologies 1 Symposium.

20 Feb 2010

Louisiana, Oklahoma, Mich., Arizona plan Medicaid cuts; N.C.'s prison health costs

The (New Orleans) Times-Picayune: Louisiana "Gov. Bobby Jindal will present his 2010-11 budget request Friday, which is expected to call for cuts to health care, education and other areas of state government as his administration outlines plans for plugging a $1 billion shortfall. ... The general-fund growth is not nearly enough to offset a loss of about $650 million in federal health-care financing, the rising cost of state pensions, automatic pay raises for state workers and inflation in health-care programs."

15 Feb 2010

Judge schedules next phase of LightLab Imaging's damages trial against Volcano and Axsun Technologies

LightLab Imaging, Inc., pioneer and leader in the development of Optical Coherence Tomography (OCT) for coronary artery applications, today reported that Trial Judge Margaret Hinkle has set March 22 for the commencement of the next phase of an ongoing trial to address damages LightLab Imaging is claiming against Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc.

10 Feb 2010

President's fiscal year 2011 budget: FDA requests $4.03 billion for promoting and protecting public health

The U.S. Food and Drug Administration is requesting $4.03 billion to promote and protect public health as part of the President's fiscal year 2011 budget - a 23 percent increase over the agency's current $3.28 billion budget.

2 Feb 2010

Palliative care program may complement patients' ongoing care with symptom management and support

Georgia Sue Huston knew she was really sick. Every time the 82-year-old woman tried to turn over in her bed in the coronary care unit at Stanford Hospital & Clinics, she’d panic because she couldn’t get enough air and because it hurt so much.

28 Jan 2010

New screening technique identifies early signs of cancer

A new technique to catch cancer early has taken an important step forward thanks to the National Physical Laboratory (NPL). NPL's 'phantoms' will ensure an exciting new screening technique can be relied upon by hospitals to identify early signs of cancer.

27 Jan 2010

States worry about Medicaid stimulus money drying up under scaled-back health bill

News outlets report on health care funding gaps in state budgets, including Massachusetts, Maryland, Georgia and Wisconsin, and the possible impact of a scaled-back federal health bill.

23 Jan 2010

Growth of OMI equipment sales to reach $400M in 2014

In vivo optical molecular imaging (OMI) is poised to move into clinical use as one of the key tools in personalized medicine, complementing more established imaging tools such as CT and MRI. Growth of equipment sales is on track to reach $400 million in 2014 and nearly $1 billion by the end of the decade.

21 Jan 2010

Acyclovir does not reduce risk of HIV transmission for people infected with both HIV and HSV-2

A five-year international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment taken twice daily to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.

21 Jan 2010

New survey: Nurses should have more influence on health care services, say opinion leaders

From reducing medical errors, to increasing the quality of care, to promoting wellness, to improving efficiency and reducing costs, a new survey finds that an overwhelming majority of opinion leaders say nurses should have more influence.

21 Jan 2010

HTDS announces possible merger with EU-based, stem-cell research company

Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica BioChem want to point the shareholders back to the press release from Oct 29, 2009, where the company announced news about a possible merger with a EU based, stem-cell research company.

20 Jan 2010

New hand-held device eliminates technical challenges involved in imaging progressive ROP in infants

Using a hand-held spectral domain optical coherence tomography (SD-OCT) imaging device, researchers have obtained high-resolution retinal scans of premature infants with progressive retinopathy of prematurity (ROP), according to a report in this month's Archives of Ophthalmology.

12 Jan 2010

CFIDS Association of America issues statement in response to XMRV study

The CFIDS Association of America issued the following statement in response to a study published in today’s edition of PLoS One that failed to detect the XMRV virus in banked samples drawn from 186 CFS patients in the United Kingdom. A study published Oct. 8, 2009 in Science reported that 68 of 101 CFS patients from clinics in the U.S. tested positive for XMRV.

7 Jan 2010

Food Safety News lists its top ten ten food safety stories of 2009

Food Safety News, the web-based newspaper that covers all things food safety, today published its list of the top ten food safety stories of the year.

29 Dec 2009

SCCA's infection control program leads to suppression of potential H1N1 pandemic

Despite a 100-fold increase in H1N1 influenza cases in the Seattle area during spring 2009, an aggressive infection control program to protect immunocompromised cancer patients and thorough screening measures resulted in no corresponding increase in H1N1 cases among the total patient population at the Seattle Cancer Care Alliance, according to a new study by researchers and physicians at Fred Hutchinson Cancer Research Center and the SCCA.

19 Dec 2009

Infection control program protects immunocompromised cancer patients from H1N1 infection

17 Dec 2009

ThromboGenics completes enrollment in second microplasmin Phase III trial

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that it has completed the enrolment of the second Phase III trial evaluating microplasmin for the non-surgical treatment of eye disease.

16 Dec 2009

Pure populations of immature cells that enable male reproduction isolated and transplanted

Reproductive researchers from the University of Pennsylvania and The Children's Hospital of Philadelphia have succeeded in isolating and transplanting pure populations of the immature cells that enable male reproduction in two species-human spermatogonia and mouse gonocytes. These germline stem cells, taken from testis biopsies, demonstrated viability following transplantation to mouse testes within a controlled laboratory setting.

15 Dec 2009

OCT News and Research

ProUroScan prostate imaging system 510(k) application: Inclement weather delays FDA processing

AMA calls for fix to Medicare's doctor payments

Cappella promotes serial IVUS analysis & Sideguard 3.25 device at Rome JIM

Louisiana, Oklahoma, Mich., Arizona plan Medicaid cuts; N.C.'s prison health costs

Judge schedules next phase of LightLab Imaging's damages trial against Volcano and Axsun Technologies

President's fiscal year 2011 budget: FDA requests $4.03 billion for promoting and protecting public health

Palliative care program may complement patients' ongoing care with symptom management and support

New screening technique identifies early signs of cancer

States worry about Medicaid stimulus money drying up under scaled-back health bill

Growth of OMI equipment sales to reach $400M in 2014

Acyclovir does not reduce risk of HIV transmission for people infected with both HIV and HSV-2

New survey: Nurses should have more influence on health care services, say opinion leaders

HTDS announces possible merger with EU-based, stem-cell research company

New hand-held device eliminates technical challenges involved in imaging progressive ROP in infants

CFIDS Association of America issues statement in response to XMRV study

Food Safety News lists its top ten ten food safety stories of 2009

SCCA's infection control program leads to suppression of potential H1N1 pandemic

Infection control program protects immunocompromised cancer patients from H1N1 infection

ThromboGenics completes enrollment in second microplasmin Phase III trial

Pure populations of immature cells that enable male reproduction isolated and transplanted

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News